Insulet (PODD) shares jump after raising full-year revenue growth guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Insulet Corporation (PODD) PT Lowered to $264 at TD Cowen
November 3, 2023 8:08 AM EDTTD Cowen analyst Joshua Jennings lowered the price target on Insulet Corporation (NASDAQ: PODD) to $264.00 (from $300.00) while maintaining a Outperform rating.... More
Insulet Corporation (PODD) PT Lowered to $180 at Baird
November 3, 2023 7:09 AM EDTBaird analyst Jeff Johnson lowered the price target on Insulet Corporation (NASDAQ: PODD) to $180.00 (from $219.00) while maintaining a Neutral rating.... More
Insulet Corporation (PODD) PT Lowered to $175 at Canaccord Genuity
November 3, 2023 6:49 AM EDTCanaccord Genuity analyst Kyle Rose lowered the price target on Insulet Corporation (NASDAQ: PODD) to $175.00 (from $355.00) while maintaining a Buy rating.... More
Insulet Corporation (PODD) PT Lowered to $250 at Piper Sandler
November 3, 2023 6:20 AM EDTPiper Sandler analyst JP McKim lowered the price target on Insulet Corporation (NASDAQ: PODD) to $250.00 (from $325.00) while maintaining a Overweight rating.... More
Insulet (PODD) Tops Q3 EPS by 34c; offers guidance
November 2, 2023 4:05 PM EDTInsulet (NASDAQ: PODD) reported Q3 EPS of $0.74, $0.34 better than the analyst estimate of $0.40. Revenue for the quarter came in at $432.7 million versus the consensus estimate of $414.32 million.
For the year ending December 31, 2023, the Company is raising its expected revenue growth to a range of 26% to... More
